Decreased Efficacy of Doxorubicin Corresponds With Modifications in Lipid Metabolism Markers and Fatty Acid Profiles in Breast Tumors From Obese vs. Lean Mice

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00306
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search